Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02084992 · ClinicalTrials.gov registry record · NA
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure
A NA study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 212
- Enrollment target
NCT02084992 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 212 participants.
The verdict
NCT02084992, a NA study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
Study Summary
This study will randomize participants with a diagnosis of congestive heart failure and at least one risk factor for hospitalization to either a tablet computer and web based disease management program or a telephone based disease management program. Both interventions are home based with heart failure education and symptom monitoring provided by nurse managers. The nurse managers are in close communication with both the participants and the participants' physicians . The components of the disease management program have been developed at Tufts Medical Center and the New England Quality Care Alliance with studies showing improved clinical outcomes, including reduced hospitalizations. The goal of this study is to transition this successful home monitoring and disease management program to a tablet computer and web-based implementation to both improve clinical outcomes (reducing hospitalizations and improving self-perceived health status) and improve provider-patient satisfaction. We hypothesize that the tablet computer based disease management will decrease heart failure hospitalizations.
Interventions
- OTHER Expanded technology disease management
- OTHER Telephonic disease management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2014-06 |
| Est. Completion | 2019-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02084992
The ClinicalTrials.gov registry entry for NCT02084992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Expanded technology disease management is the first listed.
NCT02084992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02084992 about?
NCT02084992 is a clinical study titled "A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure". This study will randomize participants with a diagnosis of congestive heart failure and at least one risk factor for hospitalization to either a tablet computer and web based disease management program or a telephone based disease management program. Both interventions are home based with heart fail...
What is the current status of trial NCT02084992?
This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2014-06. Estimated completion is 2019-09-01.
What interventions are being tested in trial NCT02084992?
The interventions under investigation include: Expanded technology disease management (OTHER), Telephonic disease management (OTHER).
Who is sponsoring clinical trial NCT02084992?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.